Lataa...
Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer’s Dementia: An Update
A significant portion of the clinical phenotype observed in Alzheimer’s disease (AD) occurs through nicotinic acetylcholine receptors (nAChRs). Degeneration of cholinergic neurons, combined with aberrant nAChR expression and activation partially through amyloid-beta peptide (Aβ)–nAChR leads to upreg...
Tallennettuna:
| Julkaisussa: | Nicotine Tob Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6379052/ https://ncbi.nlm.nih.gov/pubmed/30137524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ntr/nty116 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|